It is integrated research into the pathogenesis, diagnosis, and treatment of cardiovascular disease. The Strategic Plan’s clinical and translational research goals emphasize the transmission of knowledge between basic and clinical research so that findings in one arena rapidly inform and stimulate research in the cardiovascular field.
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain
Title : Clinical pharmacology of sotatercept - The novel quality advancement in biological therapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Optimizing the role of the electrophysiology advanced practice nurse in the hospital
Esther M Weiss, Advocate Sherman Hospital, United States